GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (LTS:0K9H) » Definitions » Equity-to-Asset

Faes Farma (LTS:0K9H) Equity-to-Asset : 0.85 (As of Jun. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Faes Farma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Faes Farma's Total Stockholders Equity for the quarter that ended in Jun. 2023 was €644.7 Mil. Faes Farma's Total Assets for the quarter that ended in Jun. 2023 was €756.5 Mil. Therefore, Faes Farma's Equity to Asset Ratio for the quarter that ended in Jun. 2023 was 0.85.

The historical rank and industry rank for Faes Farma's Equity-to-Asset or its related term are showing as below:

LTS:0K9H' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.74   Med: 0.83   Max: 0.88
Current: 0.85

During the past 13 years, the highest Equity to Asset Ratio of Faes Farma was 0.88. The lowest was 0.74. And the median was 0.83.

LTS:0K9H's Equity-to-Asset is ranked better than
87.96% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs LTS:0K9H: 0.85

Faes Farma Equity-to-Asset Historical Data

The historical data trend for Faes Farma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faes Farma Equity-to-Asset Chart

Faes Farma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 0.81 0.83 0.83 0.85

Faes Farma Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.83 - 0.85 0.85

Competitive Comparison of Faes Farma's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Faes Farma's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Faes Farma's Equity-to-Asset falls into.



Faes Farma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Faes Farma's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=662.355/776.029
=0.85

Faes Farma's Equity to Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

Equity to Asset (Q: Jun. 2023 )=Total Stockholders Equity/Total Assets
=644.695/756.543
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Faes Farma  (LTS:0K9H) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Faes Farma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Faes Farma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Faes Farma (LTS:0K9H) Business Description

Traded in Other Exchanges
Address
Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma (LTS:0K9H) Headlines

No Headlines